ERBB2 and breast cancer: van Hoesel et al. reported that LINE-1 hypomethylation was a negative prognostic factor for young breast cancer patients (≤55 years), and was associated with pT stage, lymph node metastasis, and higher age at diagnosis, but not with ER or HER2 status [23].